Cargando…
Systemic anticancer therapy (SACT) for lung cancer and its potential for interactions with other medicines
BACKGROUND: Systemic anticancer therapy, comprising chemotherapy agents alongside targeted therapies and immunotherapy, is clinically indicated for late-stage lung cancer. It is delivered in regimens often containing multiple anticancer agents as well as supportive care medicines to reduce side effe...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cancer Intelligence
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5606292/ https://www.ncbi.nlm.nih.gov/pubmed/28955400 http://dx.doi.org/10.3332/ecancer.2017.764 |